U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.83 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.11 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.46
    +2.70 (+2.55%)
     
  • Gold

    1,812.90
    +5.60 (+0.31%)
     
  • Silver

    19.77
    -0.51 (-2.50%)
     
  • EUR/USD

    1.0426
    -0.0057 (-0.54%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2103
    -0.0072 (-0.59%)
     
  • USD/JPY

    135.1750
    -0.5530 (-0.41%)
     
  • BTC-USD

    19,206.88
    -102.63 (-0.53%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    25,935.62
    -457.42 (-1.73%)
     

iPath Pure Beta Broad Commodity ETN (BCM) Hits a 52-Week High

·1 min read

For investors looking for momentum, iPath Pure Beta Broad Commodity ETN BCM is probably a suitable pick. BCM just hit a 52-week high, up 59.2% from its 52-week low price of $34.54/share.

Let’s look at the fund and its near-term outlook to gain an insight into where it might be headed:

BCM in Focus

iPath Pure Beta Broad Commodity ETN is designed to provide exposure to the Barclays Commodity Index Pure Beta TR. BCM has an AUM of $60.9 million and charges 60 basis points in annual fees.

Why the Move?

As an asset class, commodities are observed to have a positive correlation with inflation. Moreover, by providing good diversification benefits, they are also found to be uncorrelated with the broader stock market. Also, the escalation in Russia-Ukraine tensions sparked a rally in a wide range of commodities. This is making funds like BCM an impressive investment option.

More Gains Ahead?

It seems as if the iPath Pure Beta Broad Commodity ETN will remain strong, with a positive weighted alpha of 51.0, which gives cues of a further rally.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research